Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare type of renal cell carcinoma. It is a well-circumscribed multicystic mass without solid areas. The inner lining of the cystic structures is composed of clear cells.
Biomarker and diagnostic research for multilocular clear cell renal cell carcinoma has been reported in the published literature.
No clinical trials have been registered for multilocular clear cell renal cell carcinoma.
33 publications have been identified in PubMed for multilocular clear cell renal cell carcinoma. Research spans Case Report / Case Series (48%), Clinical Trial Publication (15%), and Basic Science / Preclinical (12%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 16 | 48% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 12:40 AM UTC
Program availability and eligibility requirements are set by each foundation. Contact them directly to learn more about your options.
Claim this page and your organization will be listed here for patients and families to find.
European rare disease database
Genetic and Rare Diseases Info Center
Clinical study results
5 |
15% |
Laboratory research | 4 | 12% |
Research summaries | 3 | 9% |
Disease patterns and progression | 3 | 9% |
Testing and diagnosis research | 2 | 6% |
Kwon JW (2026). [PMID: 42113263](https://pubmed.ncbi.nlm.nih.gov/42113263/). *Virchows Arch*. [Basic Science / Preclinical]
Liang C (2026). [PMID: 41675558](https://pubmed.ncbi.nlm.nih.gov/41675558/). *Urology case reports*. [Case Report / Case Series]
Toma MI (2026). [PMID: 41344358](https://pubmed.ncbi.nlm.nih.gov/41344358/). *Aktuelle Urologie*. [Review / Meta-Analysis]
Shah Rashdi PS (2026). [PMID: 42078616](https://pubmed.ncbi.nlm.nih.gov/42078616/). *Ann Med Surg (Lond)*. [Case Report / Case Series]
Zhang KJ (2026). [PMID: 41633656](https://pubmed.ncbi.nlm.nih.gov/41633656/). *Annals of clinical and laboratory science*. [Review / Meta-Analysis]
Yilin W (2025). [PMID: 40367560](https://pubmed.ncbi.nlm.nih.gov/40367560/). *European journal of radiology*. [Diagnostic / Biomarker]
Lakssir J (2025). [PMID: 39765150](https://pubmed.ncbi.nlm.nih.gov/39765150/). *International journal of surgery case reports*. [Case Report / Case Series]
Baddoura M (2025). [PMID: 40486600](https://pubmed.ncbi.nlm.nih.gov/40486600/). *Annals of medicine and surgery (2012)*. [Case Report / Case Series]
Bentestuen M (2025). [PMID: 39601076](https://pubmed.ncbi.nlm.nih.gov/39601076/). *Clinical nuclear medicine*. [Clinical Trial Publication]
Mezzapesa F (2025). [PMID: 39955191](https://pubmed.ncbi.nlm.nih.gov/39955191/). *International journal of gynecological cancer : official journal of the International Gynecological Cancer Society*. [Case Report / Case Series]
AI-curated news mentioning multilocular clear cell renal cell carcinoma
Updated Aug 28, 2026
A rare case study highlights tumor-to-tumor metastasis, where clear cell renal cell carcinoma metastasizes into lung adenocarcinoma. This finding contributes to the understanding of cancer behavior and potential treatment implications.
A study highlights the use of tumor-informed ctDNA surveillance for early detection of molecular residual disease in patients with clear cell renal cell carcinoma following radical nephrectomy and IVC thrombectomy. This approach may enhance monitoring and treatment strategies for this cancer type.